Logo Logo
Hilfe
Hilfe
Switch Language to English

Simpson, Eric L.; Blauvelt, Andrew; Silverberg, Jonathan I.; Cork, Michael J.; Katoh, Norito; Mark, Thomas; Schneider, Shannon K. R. und Wollenberg, Andreas ORCID logoORCID: https://orcid.org/0000-0003-0177-8722 (2024): Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1. In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148 [PDF, 1MB]

Dokument bearbeiten Dokument bearbeiten